CHENNAI: In a big merger within the healthcare sector, wholesale pharma distribution firm Keimed has merged with Apollo Health Co Limited (AHL), a subsidiary of Apollo Hospitals Enterprise Limited (AHEL). This takes the mixed enterprise value of the 2 entities to Rs 22,481 crore.
While Keimed is owned by the Apollo promoter’s household, omni-channel healthcare platform AHL will leverage on the previous’s huge community of greater than 70,000 pharmacies all around the nation.The integration will happen in a phased method over the subsequent 24-30 months. Veda Corporate Advisors had been the unique monetary advisors to the transactions, the assertion added.
AHL enterprise includes backend distribution providers to greater than 6,000 pharmacies throughout 1,100 cities and Apollo 24|7, a complete digital well being platform, encompassing a wide selection of healthcare providers resembling physician consultations, medication dwelling deliveries, diagnostics at dwelling, power situation administration and insurance coverage choices.
In an announcement right here on Friday, AHL stated it has entered right into a binding settlement to boost fairness capital of Rs 2,475 crore from world non-public fairness investor, Advent International. It will put money into obligatory convertible devices over two tranches to safe 12.1% stake within the merged entity, by valuing the mixed entity at an enterprise value of Rs 22,481 crore.
While AHL is valued at an enterprise value of Rs 14,478 crore, Keimed is valued at Rs 8,003 crore. Pursuant to merger, Keimed shareholders would maintain a most of 25.7% stake within the mixed entity, whereas AHEL would proceed to stay the most important controlling shareholder with a minimum of 59.2% stake.
Prathap C Reddy, chairman, Apollo Hospitals Group, stated, “With Advent’s investment and the merger of Keimed, the combined entity will be one of the country’s leading retail health companies.”
Suneeta Reddy, managing director, AHEL stated, “The merger of Keimed is a significant step in the integration of the comprehensive supply chain. The combined entity will deliver Rs 25,000 crore of revenue in three years with 7-8% EBITDA.”
Pankaj Patwari, managing director, Advent India, stated “We are attempting to build India’s largest omnichannel health-tech platform.”
While Keimed is owned by the Apollo promoter’s household, omni-channel healthcare platform AHL will leverage on the previous’s huge community of greater than 70,000 pharmacies all around the nation.The integration will happen in a phased method over the subsequent 24-30 months. Veda Corporate Advisors had been the unique monetary advisors to the transactions, the assertion added.
AHL enterprise includes backend distribution providers to greater than 6,000 pharmacies throughout 1,100 cities and Apollo 24|7, a complete digital well being platform, encompassing a wide selection of healthcare providers resembling physician consultations, medication dwelling deliveries, diagnostics at dwelling, power situation administration and insurance coverage choices.
In an announcement right here on Friday, AHL stated it has entered right into a binding settlement to boost fairness capital of Rs 2,475 crore from world non-public fairness investor, Advent International. It will put money into obligatory convertible devices over two tranches to safe 12.1% stake within the merged entity, by valuing the mixed entity at an enterprise value of Rs 22,481 crore.
While AHL is valued at an enterprise value of Rs 14,478 crore, Keimed is valued at Rs 8,003 crore. Pursuant to merger, Keimed shareholders would maintain a most of 25.7% stake within the mixed entity, whereas AHEL would proceed to stay the most important controlling shareholder with a minimum of 59.2% stake.
Prathap C Reddy, chairman, Apollo Hospitals Group, stated, “With Advent’s investment and the merger of Keimed, the combined entity will be one of the country’s leading retail health companies.”
Suneeta Reddy, managing director, AHEL stated, “The merger of Keimed is a significant step in the integration of the comprehensive supply chain. The combined entity will deliver Rs 25,000 crore of revenue in three years with 7-8% EBITDA.”
Pankaj Patwari, managing director, Advent India, stated “We are attempting to build India’s largest omnichannel health-tech platform.”
